All trading involves risk. Losses can exceed deposits.

Enzon Pharmaceuticals Inc

-0.76% -1 pts during the current or most recent trading day
Spread Bet: DFB Ways to deal
Delayed Prices
or Sign up to see live prices
Sell 130.0
Buy 130.0
Product details
or create an account to see actual figures the moment they’re released
  • Day
  • Week
  • Month
Today
or create an account to see actual figures the moment they’re released
  • Day
  • Week
  • Month
 
Copyright 2015 Thomson Reuters Ltd.  Click for restrictions
Open High Low Change % Change
132 135 125 -1 -0.76

BRIEF: For the three months ended 31 March 2015, Enzon Pharmaceuticals Inc revenues decreased 41% to $5.3M. Net income decreased 16% to $7.2M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income also reflects other net primarily gain on sale of asse decrease from $109K (income) to $0K, General and administrative increase of 15% to $583K (expense).

2015-05-19T03:33:16+00:00

Total Equity

Balance Sheet

Cash from Operating Activities

Cash Flow

Our shares technology

Start trading with IG

* If your stockbroking account is accessible under the same login as your spread betting or CFD account, you can automatically qualify for our lowest commission rate by placing at least one spread bet or CFD trade in the previous calendar month. See our full charges and fees.     

Trade shares with IG

Enjoy a £6 commission rate on UK shares when 
you add stockbroking to your existing active
IG account

Terms and condition apply*

Learn more

  • 100% of IG client accounts with open positions in this market expect the price to rise
  • 0% of IG client accounts with open positions in this market expect the price to fall
  • < 10 IG client accounts have open positions in this market
  1. Last hour
    No trades
  2. Today
    No trades
  3. This week
    No trades
  4. This month
    No trades

Related

  • Global
  • United States
Market cap
Biota Pharmaceuticals Inc USD 76.57M
Pain Therapeutics Inc USD 92.43M
Xenetic Biosciences Inc USD 31.50M
Cardiome Pharma Corp USD 159.17M
Peregrine Pharmaceuticals Inc USD 257.88M
Vivus Inc USD 260.58M
Compugen Ltd USD 322.49M